Michael Fuchs

University of Cologne — Germany

Medicine · Health Sciences

41h-index7.6kcitations264works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(194), Lung Cancer Treatments and Mutations(101), CNS Lymphoma Diagnosis and Treatment(38), Medical Imaging Techniques and Applications(29), Chronic Lymphocytic Leukemia Research(29)

Publications264 total

Effects of antibiotic prophylaxis in first-line therapy of advanced stage classic Hodgkin lymphoma: An analysis of the GHSG HD21 study
Blood·2025Open Access
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patients
HemaSphere·2025· 1 citedOpen Access
Positron Emission Tomography–Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial
Journal of Clinical Oncology·2025· 5 cited
356 | METABOLIC TUMOR VOLUME IN OLDER PATIENTS WITH ADVANCED‐STAGE CLASSIC HODGKIN LYMPHOMA: RESULTS FROM THE GHSG HD21 TRIAL
Hematological Oncology·2025Open Access
Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
Leukemia·2025Open Access
415: MULTISITE PROSPECTIVE EVALUATION OF COMPUTER AIDED DIAGNOSIS FOR REAL TIME OPTICAL DIAGNOSIS OF COLORECTAL POLYPS
Gastroenterology·2025
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG–NLG phase II BVB trial
HemaSphere·2025· 3 citedOpen Access
Metabolisches Tumorvolumen nach zwei Zyklen Chemotherapie bei Patienten mit Hodgkin-Lymphom im fortgeschrittenen Stadium: Analyse der Phase-III-Studien HD18 und HD21 der Deutschen Hodgkin Studiengruppe
Nuklearmedizin - NuclearMedicine·2025
Abscopal Effect of Radiotherapy and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: Results of the International GHSG Phase II Aern Trial
Blood·2024· 1 cited
PET-Guided Brecadd in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma: Results of the Phase 2 Part of the GHSG HD21 Trial
Blood·2024· 11 citedOpen Access
S383 Artificial Intelligence Improves Adenoma Detection Amongst Gastroenterology Fellows
The American Journal of Gastroenterology·2024
Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems
BMC Primary Care·2024· 2 citedOpen Access
My Patient With Ulcerative Colitis Recently Underwent a Total Colectomy for Severe Dysplasia. Does This Reduce the Risk That He Will Get Primary Sclerosing Cholangitis?
2024
1148 PLATELET P2Y12 INHIBITOR USE AND RISK OF COLORECTAL CANCER AND RELATED DEATH
Gastroenterology·2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma—An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group
International Journal of Radiation Oncology*Biology*Physics·2024· 4 citedOpen Access
International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
Journal of Clinical Oncology·2024· 14 cited
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis
Blood Advances·2024· 8 citedOpen Access
Estimation of Mediastinal Toxicities after Radiotherapy for Hodgkin Lymphoma—A Normal Tissue Complication Analysis of the HD16/17 Trial by the German Hodgkin Study Group
Cancers·2024· 1 citedOpen Access
Das Fundament für die persönliche Entwicklung als Führungskraft – Phase 1
Haufe eBooks·2024
Thematic: The Hepatic Encephalopathy Microbiotatransplant Trial in Cirrhosis
SSRN Electronic Journal·2024Open Access
page 1 of 14Next →

Frequent Co-authors

Andreas Engert(46), Peter Borchmann(46), Volker Diehl(36), Bastian von Tresckow(23), Helen Goergen(18), Hans Theodor Eich(17), Carsten Kobe(16), Dennis A. Eichenauer(16), Julia Meißner(16), Richard Greil(14), Markus Dietlein(13), Karolin Behringer(13), Stephanie Sasse(13), Jana Marková(12), Teresa Halbsguth(12), Boris Böll(12), Christian Baues(11), Annette Plütschow(10), Beate Klimm(10), Paul J. Bröckelmann(10)